Nonvirally Modified Autologous Primary Hepatocytes Correct Diabetes and Prevent Target Organ Injury in a Large Preclinical Model

Nelson K. F. Chen, Jen San Wong, Irene H. C. Kee et al. · 2008

Read Nonvirally Modified Autologous Primary Hepatocytes Correct Diabetes and Prevent Target Organ Injury in a Large Preclinical Model by Nelson K. F. Chen, Jen San Wong, Irene H. C. Kee et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001734.txt.

Description

Nelson K. F. Chen, Jen San Wong, Irene H. C. Kee, and their co-authors corrected diabetes in a large animal model with modified liver cells, in a 2008 PLOS ONE research article. Gene and cell therapies face limits that block wide clinical use. Using diabetes as the test case, the team sought to get around those limits.

They took primary liver cells from the animals themselves, added a nonviral insulin expression vector by electrotransfer outside the body, and returned the cells. The treated cells corrected diabetes and prevented target organ injury, per the paper's title. The full text gives the model, the cell handling, and the glucose results. Avoiding viruses as carriers removes a major safety worry for gene therapy.

Catalog record

CREATORNelson K. F. Chen, Jen San Wong, Irene H. C. Kee et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE64 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001734

Browse the full library · About the Tower of Babel